Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Acadia Pharmaceuticals Inc (ACAD)

342 + Investors. Track Smart Money conviction in ACAD. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +1
Streak
4Q ▲
Buyers last Q
54%

Smart Money Signals — ACAD

Based on 344 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 4 quarters in a row

last 6Q
For 4 consecutive quarters, more hedge funds added ACAD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
344 hedge funds hold ACAD right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +12% more funds vs a year ago

fund count last 6Q
+36 new funds entered over the past year (+12% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

187 buying158 selling
Last quarter: 187 funds bought or added vs 158 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~48 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 60 → 53 → 44 → 48. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

57% of holders stayed for 2+ years

57% conviction (2yr+) 23% medium 21% new
195 out of 344 hedge funds have held ACAD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +17% but shares only +1% — price-driven

Value
+16%
Shares
+1%
Last quarter: the total dollar value of institutional holdings rose +17%, but actual share count only changed +1%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📊

Peak discovery — momentum slowing

49 → 60 → 53 → 44 → 48 new funds/Q
New funds entering each quarter: 60 → 53 → 44 → 48. ACAD is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 63% veterans vs 24% newcomers

63% veterans 13% 1-2yr 24% new
Entry-cohort mix of 356 holders: 224 (63%) are 2+ year veterans, 46 entered 1–2 years ago, and 86 (24%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 42% AUM from top-100 funds

42% from top-100 AUM funds
59 of 344 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in ACAD. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.6
out of 10
Low Exit Risk
Exit risk score 3.6/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ACAD

In 2026 Q2, 187 hedge funds were net buyers of ACAD (48 opened a new position, 139 added to an existing one), while 158 reduced or exited (111 trimmed, 47 sold completely) — a 54% buyer ratio, indicating a slight buying edge. This marks 4 consecutive quarters of net institutional buying — a persistent conviction signal. 42% of total institutional value in ACAD is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +1 funds (more new holders than closures). Total institutional holders: 344.

Hedge Fund Ownership: ACAD

How many hedge funds hold ACAD — quarterly history vs. share price
Quarterly hedge fund ownership of ACAD vs. share price

Market Analysis: ACAD

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ACAD

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

16 top-rated funds 1 high-conviction
Consensus
5.3
/ 10
breadth
×
Elite
2.3
/ 10
conviction
Hedge Fund Positioning: ACAD
342 + Investors

Track Smart Money conviction in ACAD. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 342 343 -0.29%
13F Shares 169M 167M 1.27%
Total Value $4.29B $3.67B 16.79%
New Positions 48 44 +4
Increased Positions 136 115 +21
Closed Positions 49 38 +11
Reduced Positions 108 127 -19
Total Calls 7 8 -12.5%
Total Puts 5 7 -28.57%
PUT/CALL Ratio 0.71 0.88 Neutral

Statistics: ACAD

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

342 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ACAD. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ACAD holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Ishara Investments LP 7.62% 410,000 $10.4M
2 Baker BROS. Advisors LP 5.44% 42,912,904 $1.09B
3 Birchview Capital, LP 2.02% 171,000 $4.3M
4 Verdad Advisers, LP 2.00% 82,629 $2.1M
5 Nan Fung Group Holdings Ltd 1.98% 102,984 $2.6M
6 Rtw Investments, LP 1.54% 7,144,524 $180.8M
7 Braidwell LP 1.54% 1,646,399 $41.7M
8 Sphera Funds Management LTD. 1.18% 356,534 $9.0M
9 Frazier Life Sciences Management, L.P. 0.79% 1,438,198 $36.4M
10 Rice Hall James & Associates, LLC 0.76% 618,887 $15.7M
11 Tetragon Partners GP Ltd 0.67% 167,875 $4.2M
12 Stempoint Capital LP 0.62% 143,167 $3.6M
13 JGP Global Gestao de Recursos Ltda. 0.45% 8,110 $205K
14 Virtus Advisers, LLC 0.43% 44,384 $1.1M
15 Yorktown Management & Research Co Inc 0.39% 25,450 $644K
16 Hussman Strategic Advisors, INC. 0.37% 63,000 $1.6M
17 Virtus Investment Advisers, LLC 0.32% 55,139 $1.4M
18 Logos Global Management LP 0.27% 250,000 $6.3M
19 Phocas Financial Corp. 0.27% 77,245 $2.0M
20 PSP Research LLC 0.27% 19,766 $500K
21 Fieldview Capital Management, LLC 0.24% 33,368 $844K
22 Emerald Investment Advisers, LLC 0.22% 131,752 $3.3M
23 Edgestream Partners, L.P. 0.21% 283,301 $7.2M
24 Kelsey Financial, LLC 0.19% 10,000 $253K
25 Morgan Creek Capital Management, LLC 0.16% 9,395 $238K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Acadia Pharmaceuticals Inc (ACAD)

What does the Smart Money Trend signal show for ACAD?

Buying streak — 4 quarters in a row: For 4 consecutive quarters, more hedge funds added ACAD than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ACAD?

Slight buying edge — 54% buying: Last quarter: 187 funds bought or added vs 158 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ACAD holders?

Elite ownership — 42% AUM from top-100 funds: 59 of 344 holders are among the 100 largest funds by AUM, controlling 42% of total institutional value in ACAD. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ACAD?

57% of holders stayed for 2+ years: 195 out of 344 hedge funds have held ACAD for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →